This work holds the promise of significantly advancing our understanding of MYC-driven oncogenesis and provides critical preclinical data essential for the development of novel therapies targeting CDK8 and mTOR in MYC-driven medulloblastoma. Here, CDK8 is linked to medulloblastoma.